Clinical Trials Browser

Phase 4 × Carcinoma, Hepatocellular × lenvatinib × Clear all

NCT07160361 2025-09-16

Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

Phase 4 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04297254 2023-11-15

A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT04127396 2021-07-23

Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular